DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Patent: 5,599,557

Summary for Patent: 5,599,557

Title: Stable hydrated cephalosporin dry powder for oral suspension formulation
Abstract:A dry hydrated cephalosporin, e.g. ceftibuten having about 7 to 14% by weight of water, powder formulation, pharmaceutical compositions in the form of an oral suspension dosage form and a method of making the dry powder formulations are disclosed.
Inventor(s): Johnson; Donald A. (Miami Lakes, FL), Wearley; Lorraine (Westfield, NJ), Galeos; Rebecca (Bloomfield, NJ), Sequeira; Joel A. (New York, NY)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:08/325,400
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Process; Dosage form;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Pernix Therap
CEDAX
ceftibuten dihydrate
FOR SUSPENSION;ORAL050686Dec 20, 1995RXYes5,599,557<disabled>YMETHOD OF TREATING BACTERIAL INFECTIONS
Pernix Therap
CEDAX
ceftibuten dihydrate
FOR SUSPENSION;ORAL050686Dec 20, 1995RXYes5,599,557<disabled>YTREATMENT OF COMMUNITY ACQUIRED PNEUMONIA, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, AND ACUTE BACTERIAL SINUSITIS CAUSED BY SUSCEPTIBLE STRAINS OF DESIGNATED MICROORGANISMS IN PATIENTS 18 YEARS AND OLDER.
Pernix Therap
CEDAX
ceftibuten dihydrate
FOR SUSPENSION;ORAL050686Dec 20, 1995DISCNNo5,599,557<disabled>YTREATMENT OF COMMUNITY ACQUIRED PNEUMONIA, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, AND ACUTE BACTERIAL SINUSITIS CAUSED BY SUSCEPTIBLE STRAINS OF DESIGNATED MICROORGANISMS IN PATIENTS 18 YEARS AND OLDER.
Pernix Therap
CEDAX
ceftibuten dihydrate
FOR SUSPENSION;ORAL050686Dec 20, 1995DISCNNo5,599,557<disabled>YMETHOD OF TREATING BACTERIAL INFECTIONS
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,599,557

PCT Information
PCT FiledApril 30, 1993PCT Application Number:PCT/US93/03856
PCT Publication Date:November 11, 1993PCT Publication Number: WO93/21923

International Patent Family for Patent: 5,599,557

Country Document Number Publication Date
Austria150310Apr 15, 1997
Australia4115293Nov 29, 1993
Australia674516Jan 02, 1997
Canada2134467Nov 11, 1993
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.


« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc